Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from VGI Partners Global Investments Ltd. ( (AU:VG1) ) is now available.
VGI Partners Global Investments Ltd announced a significant update regarding its investment in Opthea Limited, a biopharmaceutical company. Opthea reported negative results from a Phase 3 clinical trial of its lead drug, leading to a suspension of its stock trading. Consequently, VG1 revalued its holdings in Opthea, affecting its net tangible asset value, which was adjusted to $1.95 per share as of March 24, 2025. This development may impact VG1’s portfolio and its stakeholders, given the potential implications of Opthea’s trial outcomes.
More about VGI Partners Global Investments Ltd.
VGI Partners Global Investments Ltd (VG1) offers investors access to a concentrated portfolio of global listed securities, managed actively with both long and short positions. The company employs a fundamental, bottom-up investment strategy, leveraging the expertise and network of Regal Partners, its investment manager.
YTD Price Performance: -3.43%
Average Trading Volume: 2
Technical Sentiment Signal: Buy
Find detailed analytics on VG1 stock on TipRanks’ Stock Analysis page.